Abstract
MANY pathogens escape the body's immune system because their surface antigenic determinants elicit an immune response that is too weak, temporary, or of the wrong type. A plausible solution to this type of problem is to put the antigenic determinant specific for the pathogen on a suitable carrier and present it to the host immune system in a way that will elicit a protective immune response of the right type, time course, and strength. This has been called the "chemical vaccine" approach1.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 99-101 |
| Number of pages | 3 |
| Journal | Nature |
| Volume | 244 |
| Issue number | 5411 |
| DOIs | |
| State | Published - Dec 1 1973 |
Fingerprint
Dive into the research topics of 'Modification of tumour growth with a defined glycoprotein antigen'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS